Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alina Russ

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
EMBO Reports|October 26, 2022
Nsp16 shields SARS-CoV-2 from efficient MDA5 sensing and IFIT1-mediated restrictionAlina Russ, Sabine Wittmann, Yuta Tsukamoto, et al.
Plos Pathogens|April 22, 2026
Live attenuated vaccination protects aged chimeric ACE2 mice from severe SARS-CoV-2 pathogenicity in vivoAlina Russ, Vera Viherlehto, Stefanie Brey, et al.
NPJ Vaccines|December 13, 2025
Adenoviral vector oropharyngeal spray immunization elicits mucosal immunity and protects against heterologous SARS-CoV-2 infectionGerrit Koopman, Petra Mooij, Maria Gaudino, et al.
Cell Host & Microbe|June 9, 2019
IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency ReactivationDominik Hotter, Matteo Bosso, Kasper L Jønsson, et al.
The Journal of Clinical Investigation|February 16, 2026
Type I IFN-dependent FcγRIV signaling in murine monocytes promotes lethal anaphylaxis during viral infectionsAbdelrahman Elwy, Hossam Abdelrahman, Julia Specht, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
EMBO Reports|October 26, 2022
Nsp16 shields SARS-CoV-2 from efficient MDA5 sensing and IFIT1-mediated restrictionAlina Russ, Sabine Wittmann, Yuta Tsukamoto, et al.
Plos Pathogens|April 22, 2026
Live attenuated vaccination protects aged chimeric ACE2 mice from severe SARS-CoV-2 pathogenicity in vivoAlina Russ, Vera Viherlehto, Stefanie Brey, et al.
NPJ Vaccines|December 13, 2025
Adenoviral vector oropharyngeal spray immunization elicits mucosal immunity and protects against heterologous SARS-CoV-2 infectionGerrit Koopman, Petra Mooij, Maria Gaudino, et al.
Cell Host & Microbe|June 9, 2019
IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency ReactivationDominik Hotter, Matteo Bosso, Kasper L Jønsson, et al.
The Journal of Clinical Investigation|February 16, 2026
Type I IFN-dependent FcγRIV signaling in murine monocytes promotes lethal anaphylaxis during viral infectionsAbdelrahman Elwy, Hossam Abdelrahman, Julia Specht, et al.
Pageof 1